Peter Spolc
Peter is a university administrator from the NSW Blue Mountains. He was diagnosed in March 2021 with stage IV ALK+ NSCLC and has since actively pursued opportunities to better understand his cancer and its treatments, and engage with the clinical and research environments. He sees his role as bringing that understanding to both practitioners and […]
Peter Young
Peter Young is a consultant interested in the human-centred design, strategy, governance, risk, and organisational transformation of service providers. He has been a member of the Board of a NSW metropolitan Local Health District and a member of the NSW Health Ministerial Advisory Committee. Peter was diagnosed with NSCLC in 2020, for which he initially […]
Matthew Peters
Matthew is professor of Respiratory Medicine at Macquarie University and Senior Specialist in Dept of Respiratory Medicine at Concord Hospital. He is a previous President of TSANZ and a passionate advocate for improvement in care and outcomes for those with and at risk of lung cancer.
Fiona Hegi-Johnson
Dr Fiona Hegi-Johnson is a Radiation Oncologist at the Peter MacCallum Cancer Centre in Victoria and Senior Research Fellow at the University of Melbourne. Clinically, she specialises in the treatment of patients with lung and breast cancer, including a subspecialty interest in stereotactic ablative body radiotherapy (SABR). Fiona is also the Chair of the TROG […]
Bryan Chan
Associate Professor Bryan Chan, BPharm (Hons I), MBBS (Hons I, Uni Medal), FRACP, MMed (Clin Epi), graduated with a Bachelor of Medicine and Surgery with first class honours and the University Medal from the University of Queensland. After being awarded Fellowship of the Royal Australasian College of Physicians, he completed a clinical research fellowship at […]
Christopher Cao
Christopher Cao is the current Thoracic Representative of the Australian and New Zealand Society of Cardiac and Thoracic Surgeons. He graduated from UNSW with First Class Honours and completed his Specialist Fellowship in Memorial Sloan Kettering Cancer Center before joining the Faculty in New York University. He is now a Clinical Professor in Sydney University […]
Tim Clay
Tim is a medical oncologist at St John of God Subiaco in WA. He completed oncology training through the Victorian Medical Oncology Training Group and an MD at St Vincents Hospital Melbourne and the University of Melbourne. He has a subspecialty interest in the management of thoracic malignancies and is active in clinical trials and […]
Wendy Cooper
Prof Wendy Cooper is a senior staff specialist pathologist in Tissue Pathology and Diagnostic Oncology at Royal Prince Alfred Hospital in Sydney and Anatomical Pathology Clinical Stream Lead for NSW Health Pathology. She has extensive experience in diagnostic and molecular pathology with special interest in thoracic pathology. She is a member of the Pathology Committee […]
Lucy Corke
Dr Lucy Corke is a consultant medical oncologist at Calvary Mater Newcastle with an interest in thoracic malignancies. She graduated from the University of Queensland and completed physician and oncology training primarily at the Royal Brisbane and Women’s Hospital. She went on to complete a two-year clinical and research fellowship in Thoracic Oncology at the […]
Rachel Roberts-Thomson
Rachel is a Medical Oncologist in Adelaide, South Australia with a strong interest in treating patients with thoracic malignancies as well as melanoma. She enjoys being a Principal Investigator on clinical trials, clinical research projects as well as supervising and teaching. Her focus has been on immuno-therapeutics and targeted therapies with the excitement that exists […]
Venessa Chin
A/Prof Venessa Chin is a researcher at the Garvan Institute of Medical Research and medical oncologist at St Vincent’s Hospital in Sydney. Specialising in genomics and cancer research, her work employs advanced genomic technologies to enhance cancer diagnosis and treatment. Her research focuses for integrating novel genomics technologies to uncover novel biomarkers and therapeutic targets.
Prunella Blinman
Deme Karikios
Victoria Bray
Graham Hall
Graham has been a Patient Advocate for Lung Cancer since his diagnosis in 2018. He saw a disparity with the survival rate and level of care, between his two primary cancers, Prostate and Lung Cancer (ALK positive mutation).
Evan Dukas
Evan has a strong commitment to health, mental wellbeing, equality, diversity, social inclusion and better lives for all people.
John Cannings
John Cannings, OAM, is a retired lawyer and consultant having been involved in the Health and Pharmaceutical sectors for over 30 years, including as an investigator/quality assurance partner in a number of Research and Development projects for the Federal Department of Health.
Anita McGrath
Anita McGrath is a member of the TOGA Consumer Panel and former member of the Australasian Lung Cancer Trials Group Scientific Committee. Anita also serves on the TOGA Committee of Audit, Risk and Finance (CARF).
Susan McCullough
Susan McCullough, OAM, has been a patient research advocate for lung cancer since her recovery from a lobectomy of her right lower lobe, due to a ‘lucky find’ of adenocarcinoma in March 2003 at the age of 47.
Jessica Donington
Dr. Donington has expertise in multimodality therapy for locally advanced lung cancer, lung cancer clinical trials, and treatment for medically high-risk patients early-stage lung cancer.
Myung-Ju Ahn
It is our pleasure to welcome Professor Myung-Ju Ahn to the 2024 TOGA ASM.
Philip Crosbie
We are privileged to welcome Professor Philip Crosbie from the University of Manchester as our international speaker at the TOGA 2024 ASM.
Michael Boyer
Prof Michael Boyer is a Medical Oncologist who has specialised in the treatment of thoracic and head and neck cancers for over 25 years. He was appointed as Chief Executive Officer at Chris O’Brien Lifehouse in 2023, having been the Chief Clinical Officer since 2011.
Sagun Parakh
Sagun is the lung cancer stream lead at the Austin Hospital. He is jointly appointed to the Olivia Newton-John Cancer Research Institute (ONJCRI) as a post-doctoral research fellow where his research focus is on biomarker and novel therapy development in solid tumours.
Alison Bolton
Alison Bolton is a consumer representative and midwife.
Teresa Faé
Teresa Faé is a person living with Stage IV lung cancer following her diagnosis in 2019 when she was 45 years of age.
Chris Brown
Chris Brown holds a Bachelor of Science in maths and statistics, and has completed the Masters of Biostatistics administered through the Biostatistics Collaboration of Australia.
Chee Lee
A/Prof Chee Lee works as a Research Fellow and Clinical Lead at the NHMRC CTC.
Vanessa Brunelli
Dr Vanessa Brunelli is a Research Fellow appointed by Queensland University of Technology.
Jon Graftdyk
Lisa Briggs
Lisa Briggs is a young mother, and allied health professional; Osteopath and Exercise Physiologist, who has been living with Stage IV Non Small Cell Lung Cancer (NSCLC) harbouring the ALK mutation since 2014.
Joe Wei
Dr. Joe Wei is currently a Medical Oncologist at Scientia Clinical Research.
Helen Westman
Helen Westman is the Lung Cancer Nurse Consultant at Royal North Shore Hospital in Sydney. She has 20 years of cancer nursing experience and has been a specialist lung cancer nurse since 2017.
Amy O’Donnell
Amy O’Donnell is a Lung Cancer Nurse Specialist at the Chris O’Brien Lifehouse. Amy was the first appointed lung cancer nurse in Lifehouse and has developed the role.
Surein Arulananda
Surein Arulananda is the Interim Director of Medical Oncology and Thoracic Oncology trials lead at Monash Health. He holds an adjunct Associate Professor position with Monash University.
Laird Cameron
Dr Laird Cameron is a Medical Oncologist specialising in lung, mesothelioma and head & neck malignancies.
